QNRX - Quoin Pharmaceuticals gets Nasdaq notification on minimum bid price requirement

Quoin Pharmaceuticals (NASDAQ:QNRX) on Wednesday said that on June 10 it had got a notification from Nasdaq that the company was not in compliance with a listing rule on minimum bid price requirement. The company has 180 days, or until Dec. 7, to regain compliance. QNRX earlier in the day said it had secured a licensing and distribution agreement with China-based Hong Kong WinHealth Pharma Group for two of QNRX's product candidates. U.S.-listed shares of QNRX closed 15% lower at $0.39.

For further details see:

Quoin Pharmaceuticals gets Nasdaq notification on minimum bid price requirement